Martha J. Demski
Director, Chimerix (United States).
Companies
- Alpha Teknova, Inc.Board member Aug 31, 2023 to now1
- Equillium, Inc.Board member Oct 11, 2018 to now2
- Chimerix (United States)Board member Apr 10, 2013 to now3
- ADMA Biologics (United States)Board member Jun 18, 2020 to Mar 8, 20234
- Adamas Pharmaceuticals (United States)Board member Apr 9, 2014 to Nov 24, 20215
- Evofem Biosciences, Inc.Board member Nov 19, 2014 to Jun 21, 20176
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ADMA Biologics (United States) ADMA56,601 shares7$604.5K at $10.68Mar 6, 2023
- Alpha Teknova, Inc. TKNO12,000 shares8$92.9K at $7.74Jul 14, 2026
- Chimerix (United States)0 shares9Apr 21, 2025
- Adamas Pharmaceuticals (United States)0 shares10Nov 24, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 14, 2026Other 12,000 shares of Alpha Teknova, Inc.8
- Jul 14, 2026Other 12,000 shares of Alpha Teknova, Inc.8
- Jun 27, 2025Sold 8,000 shares at $5.06 of Alpha Teknova, Inc.11
- Jun 17, 2025Granted 54,300 shares of Alpha Teknova, Inc.12
- Apr 21, 2025Returned to company 72,055 shares at $8.55 of Chimerix (United States)9
- Jun 26, 2024Granted 20,000 shares of Alpha Teknova, Inc.13
- May 10, 2023Bought 18,000 shares at $1.11 of Chimerix (United States)14
- Mar 6, 2023Granted 25,815 shares of ADMA Biologics (United States)7
- May 17, 2022Bought 10,000 shares at $1.61 of Chimerix (United States)15
- Mar 7, 2022Granted 26,586 shares of ADMA Biologics (United States)16
- Nov 24, 2021U 5,000 shares of Adamas Pharmaceuticals (United States)10
- Nov 24, 2021U 16,000 shares of Adamas Pharmaceuticals (United States)10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAlpha Teknova, Inc., Board member
- 2SEC EDGAREquillium, Inc., Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jul 1, 2025
- 12SEC EDGARForm 4 filed Jun 25, 2025
- 13SEC EDGARForm 4 filed Jun 27, 2024
- 14SEC EDGARForm 4 filed May 11, 2023
- 15SEC EDGARForm 4 filed May 17, 2022
- 16SEC EDGARForm 4 filed Mar 9, 2022